Collaboration Opportunities for Assay Development, Validation and Dissemination
NCI’s CPTAC program seeks collaboration with interesting parties to accelerate the uptake of proteomic assays and technologies in a rigorous fashion to enable basic and clinical studies, and its translation into patient care. There are many opportunities for collaboration with the NCI in areas of assay development, validation and dissemination. Find out more information on collaborative opportunities by contacting us at cancer.proteomics@mail.nih.gov.